Hydrochloric Acid → N-(4-Fluorobenzyl)-5-{[2-(dimethylamino)-2-oxoethyl]sulfanyl}-8-hydroxy-[1,6]napthyridine-7-carboxamide
반응식
[F:1][C:2]1[CH:27]=[CH:26][C:5]([CH2:6][NH:7][C:8]([C:10]2[C:19]([OH:20])=[C:18]3[C:13]([CH:14]=[CH:15][CH:16]=[N:17]3)=[C:12]([S:21][CH2:22][C:23]([OH:25])=O)[N:11]=2)=[O:9])=[CH:4][CH:3]=1.Cl.[CH3:29][NH:30][CH3:31].ON1C2N=CC=CC=2N=N1.Cl.CN(C)CCCN=C=NCC.C(N(C(C)C)CC)(C)C.Cl>CN(C=O)C>[F:1][C:2]1[CH:3]=[CH:4][C:5]([CH2:6][NH:7][C:8]([C:10]2[C:19]([OH:20])=[C:18]3[C:13]([CH:14]=[CH:15][CH:16]=[N:17]3)=[C:12]([S:21][CH2:22][C:23]([N:30]([CH3:31])[CH3:29])=[O:25])[N:11]=2)=[O:9])=[CH:26][CH:27]=1참가 물질
8
반응물 6
생성물 1
시약·촉매·용매 1
실험 절차
A mixture of the carboxylic acid from Step 1 (0.18 g, 0.46 mmol), dimethylamine hydrochloride (56 mg, 0.69 mmol), 1-hydroxy-7-azabenzotriazole (62 mg, 0.46 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (106 mg, 0.55 mmol), and diisopropylethylamine (0.2 mL, 0.46 mmol) in DMF (2.3 mL) was stirred at room temperature overnight. The product mixture was treated with 1 M aq HCl at 0° C. The resulting yellow solid was filtered, washed with diethyl ether. The solid was dissolved in DMSO and subjected to HPLC purification on C-18 stationary phase eluted with water/acetonitrile/TFA mobile phase. Collection and lyophilization of appropriate fractions provide the title compound as yellow solid.
후처리
- filtrationThe resulting yellow solid was filtered
- washwashed with diethyl ether
- dissolutionThe solid was dissolved in DMSO
- customsubjected to HPLC purification on C-18 stationary phase
- washeluted with water/acetonitrile/TFA mobile phase
- customCollection and lyophilization of appropriate fractions
출처 및 근거
- ORD 기록
- ord-8efa4059e5094718b0bea5ffeab91e0c
- 출처 데이터셋
- uspto-grants-2005_07
- 특허 번호
- US06921759B2
반응 노트
불러오는 중…